ARCHIVE

• Pfizer Japan Aims to Boost MR Productivity by 50% in 5 Years: Mr Bootes
  March 22, 2004

• Draft GL for Drug Testing Organizations Presented
  March 15, 2004

• REGULATORY NEWS IN BRIEF
  March 15, 2004

• Korosho to Promote Prevention of the Need for Nursing Care
  March 15, 2004

• Generic Drug Use Increasing Steadily at Pref. Hospitals: PJ Survey
  March 15, 2004

• Pfizer Working to Boost Motivation, Research Efficiency
  March 15, 2004

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  March 15, 2004

• Takeda to Remain No. 1 in Priority Fields under New Marketing System: Mr Yamaoka
  March 15, 2004

• Japanese Healthcare Q&A (6)
  March 15, 2004

• Yamanouchi to Promote Stasis in Patients with Mild Diabetes
  March 15, 2004

• Fujisawa's R&D Pipeline Updated
  March 15, 2004

• Banyu to Focus More Resources on Marketing of Fosamac
  March 15, 2004

• New GL for Cerebral Apoplexy Released
  March 15, 2004

• Teijin Pharma to Expand MR Force to Boost Sales of Bonalon
  March 15, 2004

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  March 15, 2004

• Sumitomo: FY2003 Sales to Fall Short of Forecast, but Profits Go as Expected
  March 15, 2004

• DIAGNOSTIC NEWS IN BRIEF
  March 15, 2004

• Eisai Formally Decides to Adopt "Company with Committees" System
  March 15, 2004

• OTC NEWS IN BRIEF
  March 15, 2004

• Symposium Discusses Use of Bar Codes to Prevent Medication Errors
  March 15, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 541
• 542
• 543
• 544
• 545
• 546
• 547
• 548
• 549
• …
• Next ›
• 最終 »